Beginning in mid-February 2008, the 1997-2007 online version of the Science Watch® newsletter, ESI-Topics.com, and in-cites.com, will all be featured together on the redesigned ScienceWatch.com. All previous content from the three sites will be permanently archived, and remain accessible from any existing bookmarks to the archived pages. No new content will be added to this site. Updates and new content (updated biweekly) are available at ScienceWatch.com now.

Fast Moving Fronts Comments

Return to menu of Fast Moving Fronts

ESI Special Topics, January 2006
Citing URL: http://www.esi-topics.com/fmf/2006/january06-FrankBuchholz.html

From •>>January 2006

Frank Buchholz answers a few questions about this month's fast moving front in the Multidisciplinary field.

Field: Multidisciplinary
Article: An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division
Authors: Kittler, R;Putz, G;Pelletier, L;Poser, I;Heninger, AK;Drechsel, D;Fischer, S;Konstantinova, I;Habermann, B;Grabner, H;Yaspo, ML;Himmelbauer, H;Korn, B;Neugebauer, K;Pisabarro, MT;Buchholz, F
Journal: NATURE, 432 (7020): 1036-1040, DEC 23 2004
Addresses: Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.
Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
Scion Comp Innovat GmbH, D-01307 Dresden, Germany.
Max Planck Inst Mol Genet, D-14195 Berlin, Germany.
RZPD Ressourcenzentrum Genomforsch, D-69120 Heidelberg, Germany.


   Why do you think your paper is highly cited?


“Our work puts whole genome RNAi screens in mammalian cells at reach for laboratories, that otherwise would not be able to perform such experiments.”

Our paper is one of the first publications describing an RNAi screen in mammalian cells. It portrays a screen that identified novel genes required for proper cell division, a research area that is relevant to many scientists. Our work also presents an effective, specific, and cost-effective way to generate RNAi libraries through the use of endoribonuclease-prepared siRNAs.

   Does it describe a new discovery or a new methodology that’s useful to others?

RNAi is probably one of the most exciting and important discoveries in the natural sciences in recent years. Our work describes a new method on how to make this technology efficient and cost-effective for use in large-scale and in high-throughput experiments. Our work puts whole-genome RNAi screens in mammalian cells within reach for laboratories, which otherwise would not be able to perform such experiments.

   Could you summarize the significance of your paper in layman’s terms?

The sequencing of whole genomes has provided scientists with the blueprint of life and has identified all genes that code for proteins in the cell. A next important step towards a better understanding of how a cell works is figuring out the function of each of these genes. RNAi is a method that allows the specific silencing of each gene within a cell. The consequence of this silencing can then be studied and based on observed phenotypes from which conclusions can be drawn for the function of the gene. In our case we used RNAi to find genes that are involved in cell division, a process that happens uncontrollably in cancer cells. A better understanding of cell division may help to identify novel therapies against cancer.

   How did you become involved in this research, and were there successes or failures along the way?

I was lucky to work in a lab where scientists worked with different organisms, including flies and mice. When the mechanism of RNAi was dissected in C.elegans and Drosophila cells, a postdoc previously working in Drosophila had the great idea to try E.coli RNaseIII as a "substitute" for Dicer to make a pool of siRNAs from long dsRNA in vitro. When he presented the results in a group meeting, I realized the potential of this technology for functional genomic studies in mammalian cells.

   What are the social or political implications of your research?

RNAi has far reaching consequences for research performed in many areas important for improving human health. The technology speeds up scientific discovery and is also a promising method for novel therapies.End

Frank Buchholz
Research Group Leader
Max Planck Institute of Molecular Cell Biology & Genetics (MPI.CBG)
Dresden, Germany

Return to Fast Moving Fronts | Return to Special Topics main menu
 

ESI Special Topics, January 2006
Citing URL: http://www.esi-topics.com/fmf/2006/january06-FrankBuchholz.html

ScienceWatch.com - Tracking Trends and Perfomance in Basic Research
Go to the new ScienceWatch.com

Write to the Webmaster with questions/comments. Terms of Usage.
The Research Services Group of Thomson Scientific |
(c) 2008 The Thomson Corporation.